Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Journal of Environmental Pathology, Toxicology and Oncology
Impact-faktor: 1.241 5-jähriger Impact-Faktor: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.2015013477
pages 125-131

Attenuation of Leukemia/Lymphoma-Related Factor Protein Expression Inhibits Glioma Cell Proliferation and Invasion

Rui Huang
Department of Neurosurgery, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, China
Tao Xie
Department of Neurology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, China
Yin Zhao
Rebuild and Repair Center of Hand and Foot, The Second Affiliated Hospital of Jilin University, Changchun, Jilin, China
Chun Yao
Hospital

ABSTRAKT

Overexpression of leukemia/lymphoma-related factor (LRF), which is an erythroid myeloid ontogenic factor protein, occurs in different cancers, including glioma. LRF is also reported to have an oncogenic activity in various human cancers. This study investigated the effect of LRF knockdown on the regulation of glioma growth. LRF short hairpin RNA (shRNA) suppressed the expression of LRF protein in a glioma cell line (GL261-EGFP) compared to the negative control vector−transfected glioma cells. LRF knockdown also reduced glioma cell viability and enhanced cisplatin-induced apoptosis in glioma cells. AKT activation and the expression of various cell cycle−related genes were inhibited following LRF knockdown. The effect on growth and migration is related to dose response results of AKT and nuclear factor-kappa B (NF-κB) inhibitors. These data demonstrate that LRF may play a role in glioma progression, suggesting that inhibition of LRF expression using LRF shRNA should be further evaluated as a novel target for the control of glioma.


Articles with similar content:

Effect of Benzo[a]pyrene on the Production of Vascular Endothelial Growth Factor by Human Eosinophilic Leukemia EoL-1 Cells
Journal of Environmental Pathology, Toxicology and Oncology, Vol.30, 2011, issue 3
Chris Kong-Chu Wong, Naiki K. Mak, Kok-Nam Leung, Lai-Sheung Chan, Ngok-Shun Wong, Chun-Kwok Wong, Jie Gu
Knockdown of ECHS1 Protein Expression Inhibits Hepatocellular Carcinoma Cell Proliferation via Suppression of Akt Activity
Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 3
Wei Zeng, Chun Yao, Qiu-hui Tan, Jun-pei Xie, Yi-chen Dai, Yuan-yuan Lin, Zhang-xing Chen
Bifunctional Role of Kruppel-Like Factor 4 in Hematological Malignancies
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Sara Huerta-Yepez, Otoniel Martinez-Maza, Mario I. Vega, Liliana Moreno Vargas, Luz A. Franco-Cea, Mario Morales-Martinez
Dual Roles of Raf-1 Kinase Inhibitor Protein in the Regulation of Both Tumor Cell Resistance to Apoptotic Stimuli and Epithelial to Mesenchymal Transition
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 1
Stavroula Baritaki, Kam C. Yeung, Benjamin Bonavida
Yin Yang 1 Is a Tumor Immune-Suppressor Gene Product
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 1-2
Stavroula Baritaki